Free Trial

Lonza Group (LZAGY) Stock Forecast & Price Target

Lonza Group logo
$67.44 -0.53 (-0.78%)
As of 10/9/2025 03:59 PM Eastern

Lonza Group - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Sell
0
Hold
1
Buy
1

Based on 2 Wall Street analysts who have issued ratings for Lonza Group in the last 12 months, the stock has a consensus rating of "Buy." Out of the 2 analysts, 1 has given a hold rating, and 1 has given a strong buy rating for LZAGY.

Consensus Price Target

N/A

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for LZAGY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Lonza Group and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LZAGY Analyst Ratings Over Time

TypeCurrent Forecast
10/10/24 to 10/10/25
1 Month Ago
9/10/24 to 9/10/25
3 Months Ago
7/12/24 to 7/12/25
1 Year Ago
10/11/23 to 10/10/24
Strong Buy
1 Strong Buy rating(s)
2 Strong Buy rating(s)
2 Strong Buy rating(s)
2 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
1 Buy rating(s)
Hold
1 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Forecasted UpsideN/AN/AN/AN/A
Consensus RatingBuyStrong BuyStrong BuyStrong Buy

LZAGY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

LZAGY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Lonza Group Stock vs. The Competition

TypeLonza GroupMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.33
2.52
Consensus RatingBuyHoldModerate Buy
Predicted UpsideN/A1,058.80% Upside172.89% Upside
News Sentiment Rating
Positive News

See Recent LZAGY News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
9/22/2025Zacks Research
0 of 5 stars
 DowngradeStrong-BuyHold
11/27/2024Redburn Atlantic
5 of 5 stars
J. Clark
Not Rated
UpgradeStrong-Buy
10/9/2024The Goldman Sachs Group
3 of 5 stars
J. Quigley
Not Rated
UpgradeStrong-Buy
6/23/2024Berenberg Bank
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
2/2/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 UpgradeHoldBuy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 08:44 AM ET.


Should I Buy Lonza Group Stock? LZAGY Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, October 7, 2025. Please send any questions or comments about these Lonza Group pros and cons to contact@marketbeat.com.

Lonza Group
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Lonza Group AG:

  • The current stock price is around $65, which may present a buying opportunity for investors looking for value in the pharmaceutical and biotech sectors.
  • Lonza Group AG has recently experienced a significant increase in trading volume, indicating heightened investor interest and potential momentum in the stock.
  • Analysts have rated Lonza Group AG with a consensus rating of "Buy," suggesting positive sentiment and potential for price appreciation.
  • The company has a solid financial position, with a quick ratio of 1.04 and a current ratio of 1.52, indicating good short-term liquidity and ability to meet obligations.
  • Lonza Group AG operates in diverse markets, including pharmaceuticals and nutrition, which can provide stability and growth opportunities across different sectors.

Lonza Group
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Lonza Group AG for these reasons:

  • Recent research notes have downgraded the stock from a "strong-buy" to a "hold" rating, which may indicate a lack of confidence in short-term performance.
  • There has been a notable drop in short interest, suggesting that some investors may be betting against the stock, which could reflect negative sentiment.
  • The stock has shown volatility, with a 1-year high of $73.29 and a low of $55.57, indicating potential risks for investors concerned about price fluctuations.
  • Despite a strong market presence, the company faces competition in the biotech and pharmaceutical sectors, which could impact its market share and profitability.
  • Recent trading activity has shown mixed signals, with the stock price fluctuating around previous closing values, which may concern investors about its stability.

LZAGY Forecast - Frequently Asked Questions

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Lonza Group in the last twelve months. There is currently 1 hold rating and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" LZAGY shares.

According to analysts, Lonza Group's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Over the previous 90 days, Lonza Group's stock had 1 downgrade by analysts.

Lonza Group has been rated by research analysts at Zacks Research in the past 90 days.

Analysts like Lonza Group more than other "medical" companies. The consensus rating for Lonza Group is Buy while the average consensus rating for "medical" companies is Hold. Learn more on how LZAGY compares to other companies.


This page (OTCMKTS:LZAGY) was last updated on 10/10/2025 by MarketBeat.com Staff
From Our Partners